Starting a medical device company requires considering many complex interrelated factors for success, including regulatory strategy, reimbursement strategy, intellectual property, quality systems, and clinical evidence. Medical device startups must define an unmet clinical need, develop the product to address that need through multiple iterations, secure intellectual property protection, obtain regulatory clearance, establish clinical evidence of safety and efficacy, ensure reimbursement and adoption into clinical practice standards of care. A case study of developing a treatment for sacroiliac joint syndrome illustrates these interconnected activities from defining the problem to commercialization and standardization of the procedure.
VisionD aims to create inexpensive hardware and software for early diagnostic screening of diabetic retinopathy to prevent blindness. Their product is a handheld camera and software that allows for screening and is competitively priced, easy to use, and can reach more patients. Their marketing campaign called "Look Ahead with VisionD" will create awareness among doctors and consumers through various channels to educate them on the benefits of early detection and how it can help practices grow. Their social media strategy involves using platforms like YouTube, Facebook, LinkedIn and Twitter to connect with customers, doctors and medical professionals.
VisionD aims to create inexpensive hardware and software for early diagnostic screening of diabetic retinopathy to prevent blindness. Their product is a handheld camera and software that allows for screening and is competitively priced, easy to use, and can reach more patients. Their marketing campaign called "Look Ahead with VisionD" will create awareness among doctors and consumers through various channels to educate them on the benefits of early detection and how it can help practices grow. Their social media strategy involves using platforms like YouTube, Facebook, LinkedIn and Twitter to connect with customers, doctors and medical professionals.
Dr. Ravi Dhar on "Technology Barriers & Intellectual Property" Interview 2014Dr. Ravi Dhar
The document discusses several challenges faced by the biotech industry in India related to intellectual property and technology, including patents blocking collaboration and conflicts between multiple patent owners. It outlines issues such as lack of infrastructure, skilled personnel, funding for clinical trials, and long regulatory approval times. The document provides suggestions for addressing these challenges, such as developing technology transfer hubs, conducting workshops on regulatory issues, and engaging in public-private partnerships. It emphasizes the importance of market analysis, freedom to operate analysis, and prior art searches before patent filing.
MPG Life Sciences Software Market Snapshot October 2020Madison Park Group
We are pleased to present our life sciences software market snapshot for October 2020.
Madison Park Group is a unique investment banking firm that takes a "strategy first" approach to advising software companies. Our partners have developed and advised numerous successful companies as operators, investors and investment bankers.
Rohan Khanna, Jonathan Adler and James Tomasullo spearhead the firm's efforts in the space.
The document discusses key considerations for developing medical devices with a global market strategy in mind. It outlines common mistakes made during development like poor reimbursement planning, lack of human factors research, and unclear regulatory pathways. It emphasizes the importance of bringing together all development disciplines like regulatory, compliance, testing, and reimbursement in a unified strategy from the beginning. Finally, it discusses best practices like working closely with regulatory agencies early, having a platform for evolution, and maintaining strong communication across functions and stakeholders.
Starting a medical device company requires considering many complex interrelated factors for success, including regulatory strategy, reimbursement strategy, intellectual property, quality systems, and clinical evidence. Medical device startups must define an unmet clinical need, develop the product to address that need through multiple iterations, secure intellectual property protection, obtain regulatory clearance, establish clinical evidence of safety and efficacy, ensure reimbursement and adoption into clinical practice standards of care. A case study of developing a treatment for sacroiliac joint syndrome illustrates these interconnected activities from defining the problem to commercialization and standardization of the procedure.
VisionD aims to create inexpensive hardware and software for early diagnostic screening of diabetic retinopathy to prevent blindness. Their product is a handheld camera and software that allows for screening and is competitively priced, easy to use, and can reach more patients. Their marketing campaign called "Look Ahead with VisionD" will create awareness among doctors and consumers through various channels to educate them on the benefits of early detection and how it can help practices grow. Their social media strategy involves using platforms like YouTube, Facebook, LinkedIn and Twitter to connect with customers, doctors and medical professionals.
VisionD aims to create inexpensive hardware and software for early diagnostic screening of diabetic retinopathy to prevent blindness. Their product is a handheld camera and software that allows for screening and is competitively priced, easy to use, and can reach more patients. Their marketing campaign called "Look Ahead with VisionD" will create awareness among doctors and consumers through various channels to educate them on the benefits of early detection and how it can help practices grow. Their social media strategy involves using platforms like YouTube, Facebook, LinkedIn and Twitter to connect with customers, doctors and medical professionals.
Dr. Ravi Dhar on "Technology Barriers & Intellectual Property" Interview 2014Dr. Ravi Dhar
The document discusses several challenges faced by the biotech industry in India related to intellectual property and technology, including patents blocking collaboration and conflicts between multiple patent owners. It outlines issues such as lack of infrastructure, skilled personnel, funding for clinical trials, and long regulatory approval times. The document provides suggestions for addressing these challenges, such as developing technology transfer hubs, conducting workshops on regulatory issues, and engaging in public-private partnerships. It emphasizes the importance of market analysis, freedom to operate analysis, and prior art searches before patent filing.
MPG Life Sciences Software Market Snapshot October 2020Madison Park Group
We are pleased to present our life sciences software market snapshot for October 2020.
Madison Park Group is a unique investment banking firm that takes a "strategy first" approach to advising software companies. Our partners have developed and advised numerous successful companies as operators, investors and investment bankers.
Rohan Khanna, Jonathan Adler and James Tomasullo spearhead the firm's efforts in the space.
The document discusses key considerations for developing medical devices with a global market strategy in mind. It outlines common mistakes made during development like poor reimbursement planning, lack of human factors research, and unclear regulatory pathways. It emphasizes the importance of bringing together all development disciplines like regulatory, compliance, testing, and reimbursement in a unified strategy from the beginning. Finally, it discusses best practices like working closely with regulatory agencies early, having a platform for evolution, and maintaining strong communication across functions and stakeholders.
A downfall of the Indian Economy & the increasing number of daily positive cases, COVID-19 or a coronavirus has impacted India in many ways, companies are losing their productivity, and are also facing problems in terms of finance and other resources.
As we know that “necessity is the mother of invention” and our, Entrepreneurial & Innovation environment leads us to hope. Entrepreneurs are known to be problem solver, they are looking at the different sides of the problem and finding out the niche market by segmenting the customer base. By applying and adopting the digital transformation they are finding out various opportunities that are available and will be available post-COVID-19.
Collaboration, convergence, and co-creation, keeping this in mind, entrepreneurs are facing this challenging virus.
This project has received funding from the European Union's Horizon 2020 programme. The document discusses commercializing innovation, including developing prototypes, testing MVPs, launching products, and scaling. It covers challenges like funding gaps, regulatory differences, and ensuring a product-market fit throughout the commercialization process.
Healthcare Insights Callum Bir Deloitte Disruptive Innovations In HcCallum Bir
This document discusses disruptive innovations in healthcare, including opportunities for and barriers to self-care using technology, chronic care management, evidence-based care using personal monitoring devices, prevention of chronic diseases, and keeping people healthy through wellness programs and incentives. Growth areas include online tools for patients, mobile health apps, chronic disease management, and social media for various healthcare uses. However, barriers include limited adoption by providers, data governance issues, lack of awareness, and the need for sustainable business models. Trust, financial alignment between stakeholders, and government support will also be important to address.
Biocon India Group should expand its operations through Clinigene, its clinical research subsidiary, to capture opportunities in the growing clinical trials market in India. The summary is:
1) Clinigene should expand from bioequivalence and bioavailability studies into clinical trials over 2 years by developing expertise, recruiting qualified staff, and securing clinical trial projects.
2) Factors to consider include maintaining Biocon's public image on ethical issues, protecting its organizational culture, and avoiding expertise divergence from other Biocon operations.
3) A phased expansion over 2 years allows Clinigene to establish itself while Biocon drafts an expansion plan and scouts required resources, minimizing risks to its reputation and operations.
This document summarizes findings from a field trip to Silicon Valley regarding options for Finnish healthtech startups to enter the US market. It outlines trends in health technology, interesting new startups, and the innovation ecosystem in Silicon Valley. It then discusses US gateway options such as accelerators, partners, and venture capital firms investing in health. Finally, it provides recommendations on understanding the market stage and category to determine the best entry approach.
El 12 de mayo de 2017 celebramos en la Fundación Ramó Areces una jornada con IS Global y Unitaid sobre enfermedades transmitidas por vectores, como la malaria, entre otras.
This document describes the Medical Device Gateway (MDG) program, a Chinese-Finnish network aimed at commercializing medical device technologies. The program seeks to bring Chinese medical device innovations to European markets through Finnish companies, and to open Chinese markets to Finnish medical ventures. It identifies opportunities in the large and growing Chinese IVD market and regulatory changes making it more accessible. The document outlines the program's operations of establishing strategic partnerships between Finnish and Chinese organizations to more quickly develop and place new products on global markets.
The post-COVID Value Shift & How MedTech Companies can CapitalizeGreenlight Guru
The ongoing COVID-19 pandemic has fundamentally shifted the perception of value globally. The healthcare industry, and MedTech (Devices, Diagnostics and Digital Health) stand to benefit enormously. While the world waits for a vaccine, it has been MedTech companies and their solutions that have protected healthcare workers, kept patients alive, and been the focus of government policy and investment. The policy and funding shifts have been aligned to value-based healthcare principals, of which MedTech was already a leader. Discover how you can align your organization, and engage with key stakeholders to capitalize on this massive shift in value perception.
Takeaways:
- How the fundamental structure of healthcare is set to change
-How this fundamental change will benefit MedTech companies
-What you need to do in order to make this change sustainable within your organization
This session took place live at the Greenlight Guru True Quality Virtual Summit, a three-day event for medical device professionals to learn to get their devices to market faster, stay ahead of regulatory changes, and use quality as their multiplier to grow their device business.
The document discusses strategies for collecting and analyzing COVID-19 related data to help pharmaceutical executives make decisions. It instructs the reader to prepare a 4-5 slide presentation comparing new COVID case rates before and after vaccination in their home country. Suggestions for the presentation include collecting data on vaccine hesitancy, infections without medical attention, and vaccine complications. References are provided on crude oil prices and Nigeria's COVID vaccination dashboard.
EMERGENCE OF NEW DIGITALIZATION TECHNIQUES IN ORGANISATIONS IN.pptxArunimaHazra2
The document discusses the emergence of new digitalization techniques adopted by organizations during the COVID-19 pandemic. It describes how the pandemic disrupted organizations, issues they faced, and the three-step response pattern of emergency response, crisis management, and focusing on the future. It also discusses digital trends that are likely to remain, including increased telework and adoption of digital solutions. The pandemic accelerated digital transformation, changing mindsets from "good-to-have" to "must-have." While some organizations adapted smoothly, the economic situation forced others to change. Overall, the pandemic highlighted the benefits of digital transformation.
1. Product development partnerships (PDPs) bridge the gap between industry and patients to develop diagnostic solutions for diseases that lack profitable treatments by collaborating with public and private partners.
2. 21 of the 28 diseases that primarily impact developing countries lack essential diagnostic tools, and companies have little incentive to invest in research and development without potential for profits.
3. PDPs can accelerate the development and access to diagnostics more quickly and cost-effectively than either the public or private sector alone by leveraging contributions from various partners.
The document summarizes a webinar on COVID-19 therapies and vaccines. It discusses the state of development for different therapeutic modalities, including antivirals, antibodies, and immunomodulators. It also discusses vaccine platforms under investigation, including nucleic acid, protein subunit, virus, and viral vector vaccines. Timelines for clinical trials and availability of leading candidates are provided. The need to prepare for large-scale production and delivery to meet target population goals is discussed. Partnerships across different organizations are highlighted as critical for success.
Through practical case studies and industry specific analysis sessions, Medical Device UDIs & Traceability Forum Europe 2015 is geared around strengthening your regulatory infrastructure, maintaining productivity and ensuring ROI from your UDI projects.
View the full agenda here: bit.ly/MedicalDeviceUDI2015Agenda
Alternatively, email enquire@iqpc.co.uk or call +44 (0)207 036 1300 for a copy.
DIGITAL TRANSFORMATION IN THE NEXT NORMAL: How consumerism, technology and th...Damo Consulting Inc.
What was assumed to be a transformation journey stretching over several years has now shrunk to a matter of months, and the pace of change is accelerating. Paddy Padmanabhan and Ed Marx, the authors of the first book published on healthcare digital transformation since the pandemic hit us, discuss 5 major themes in healthcare’s digital transformation, and what the next normal looks like.
They will present findings from recent research on how mid-tier systems must approach transformation.
1. How COVID-19 accelerated the timelines for transformation
2. Why health systems must go beyond just telehealth
3. Why digital leaders must develop enterprise roadmaps
4. How CIO’s can transform IT to support digital health
5. How technology decisions must deliver enterprise-level impact
The healthcare industry is being disrupted by technology and a shift to greater patient / individual empowerment. This represents a formidable opportunity for healthcare in Asia. What catalyst role could / should strategics play in Asia healthcare innovation and how?
The impact on covid 19 on business and how to reposition for success - intens...Intense
The spread of the COVID-19 virus has caused governments around the world including Nigeria to impose lockdowns on movement and this has affected most businesses adversely. We did some research to find out the challenges businesses are experiencing at this time and what areas they need help in to adapt to these drastic changes.
This presentation contains insights on what businesses can expect to happen in the short, medium and long term while also providing solutions to thrive in the new economy which will be largely digital.
Suddenly the risk-reward balance has shifted dramatically. Anyone with basic cold symptoms is being advised to stay home. And many people can no longer travel with COVID-19 in their community.
What if you can no longer visit your sites? Are you ready to use the tools at your disposal as contingency or risk-mitigation strategies to keep your studies going and ensure your patients can access their study medication and remain safely monitored?
During this virtual discussion forum were putting our minds together to combat the impact of the Coronavirus outbreak on clinical trials, and be better prepared in the future.
Baptist Health- Engineering the Future of HealthcareLevi Shapiro
Presentation by Mark Coticchia, Chief Innovation Officer, Baptist Health, for mHealth Israel community, September, 2023. Baptist Health has internationally renowned centers of excellence in cancer, cardiovascular care, orthopedics and sports medicine, and neurosciences.
A not-for-profit organization supported by philanthropy and committed to its faith-based charitable mission of medical excellence, Recognized by Fortune as one of the 100 Best Companies to Work For in America and by Ethisphere as one of the World’s Most Ethical Companies.Innovation is paramount to health system’s performance and reputation.
Becker’s 2019 Advisory Board survey revealed innovation and technology ranked as the top priority among healthcare finance professionals - up from eighth in 2018. 90% healthcare/life science leaders agree that the pandemic will fundamentally change the way they do business, requiring new products, services, processes, and business models (McKinsey: Innovation Through Crisis Survey). Innovation has been proven to help health systems in many ways. A capability and culture of innovation accomplish numerous goals:
Innovation capability and culture improve the care and work environment. They enhance the reputation through recognition for discoveries made at and through Baptist Health. They aid in the recruitment and retention of top talent. And they help systems harness money that otherwise would be leaving the system – licensing revenues and investment returns and corporate research support and donor revenues. Successful Programs - Common Underpinnings. Innovation as a strategic, institutional priority
Program built on institutional assets and centers of excellence
Experienced, professional team
Technology development and sourcing, Dedicated, long term support. Doing healthcare innovation well at a large enterprise takes a highly specialized team and skill set. Collectively, they need to have deep knowledge of healthcare regulation, medical procedures, patient safety, business development, transactions, business law, innovation markets, entrepreneurship, venture capital, commercialization, tech transfer, organizational change management, and much more. Programs- services, technology management, corporate co-creation, global medical service lines and facilities; Focus on market opportunity vs. technology; Select & concentrate on winners; Operate as a business; Proactive in new company formation; Progress, milestones, preliminary results; Building New Innovation Pathways; Improving Treatment for Cancer Patients; Predicting & Preventing Heart Attacks; Improving Outcomes in Cardiac Care; Enhancing a Culture of Innovation at Baptist Health & South Florida; Cleerly, TriVentures, COTA; Innovation is paramount to health system’s performance and reputation.
Baptist Health has established an innovation function predicated on best practices and tailored to its assets and the opportunities extending from Miami’s economic growth
The document discusses PositiveID's portfolio of products for biological detection and diagnostics. It summarizes key products like Firefly Dx, a handheld molecular diagnostic device, and M-BAND, an automated bio-threat detection system. It also discusses recent acquisitions of E-N-G, a provider of mobile labs, and Caregiver, a non-contact thermometer. PositiveID aims to commercialize Firefly Dx in 2018 after field testing in 2017. The company has experienced growing revenue, reaching $2.9 million in 2015 and projecting $5-6 million for 2016 through its expanding product lines and recent acquisitions.
Innovating for health mObile Health perspectiveRuchi Dass
In the face of the enormous challenges of managing chronic diseases, delivery innovations appear to have the most impact when multiple parties (e.g., physicians, nurses, payors) interact seamlessly to provide the best possible patient care over an extended period of time. Such integrated models have the potential to reduce costs dramatically, while increasing patient satisfaction and clinical quality
THE SPECIAL SENCES- Unlocking the Wonders of the Special Senses: Sight, Sound...Nursing Mastery
Title: Unlocking the Wonders of the Special Senses: Sight, Sound, Smell, Taste, and Balance
Introduction:
Welcome to our captivating SlideShare presentation on the Special Senses, where we delve into the extraordinary capabilities that allow us to perceive and interact with the world around us. Join us on a sensory journey as we explore the intricate structures and functions of sight, sound, smell, taste, and balance.
The special senses are our primary means of experiencing and interpreting the environment, each sense providing unique and vital information that shapes our perceptions and responses. These senses are facilitated by highly specialized organs and complex neural pathways, enabling us to see a vibrant sunset, hear a symphony, savor a delicious meal, detect a fragrant flower, and maintain our equilibrium.
In this presentation, we will:
Visual System (Sight): Dive into the anatomy and physiology of the eye, exploring how light is converted into electrical signals and processed by the brain to create the images we see. Understand common vision disorders and the mechanisms behind corrective measures like glasses and contact lenses.
Auditory System (Hearing): Examine the structures of the ear and the process of sound wave transduction, from the outer ear to the cochlea and auditory nerve. Learn about hearing loss, auditory processing, and the advances in hearing aid technology.
Olfactory System (Smell): Discover the olfactory receptors and pathways that enable the detection of thousands of different odors. Explore the connection between smell and memory and the impact of olfactory disorders on quality of life.
Gustatory System (Taste): Uncover the taste buds and the five basic tastes – sweet, salty, sour, bitter, and umami. Delve into the interplay between taste and smell and the factors influencing our food preferences and eating habits.
Vestibular System (Balance): Investigate the inner ear structures responsible for balance and spatial orientation. Understand how the vestibular system helps maintain posture and coordination, and explore common vestibular disorders and their effects.
Through engaging visuals, interactive diagrams, and insightful explanations, we aim to illuminate the complexities of the special senses and their profound impact on our daily lives. Whether you're a student, educator, or simply curious about how we perceive the world, this presentation will provide valuable insights into the remarkable capabilities of the human sensory system.
Join us as we unlock the wonders of the special senses and gain a deeper appreciation for the intricate mechanisms that allow us to experience the richness of our environment.
Cyclothymia Test: Diagnosing, Symptoms, Treatment, and Impact | The Lifescien...The Lifesciences Magazine
The cyclothymia test is a pivotal tool in the diagnostic process. It helps clinicians assess the presence and severity of symptoms associated with cyclothymia.
A downfall of the Indian Economy & the increasing number of daily positive cases, COVID-19 or a coronavirus has impacted India in many ways, companies are losing their productivity, and are also facing problems in terms of finance and other resources.
As we know that “necessity is the mother of invention” and our, Entrepreneurial & Innovation environment leads us to hope. Entrepreneurs are known to be problem solver, they are looking at the different sides of the problem and finding out the niche market by segmenting the customer base. By applying and adopting the digital transformation they are finding out various opportunities that are available and will be available post-COVID-19.
Collaboration, convergence, and co-creation, keeping this in mind, entrepreneurs are facing this challenging virus.
This project has received funding from the European Union's Horizon 2020 programme. The document discusses commercializing innovation, including developing prototypes, testing MVPs, launching products, and scaling. It covers challenges like funding gaps, regulatory differences, and ensuring a product-market fit throughout the commercialization process.
Healthcare Insights Callum Bir Deloitte Disruptive Innovations In HcCallum Bir
This document discusses disruptive innovations in healthcare, including opportunities for and barriers to self-care using technology, chronic care management, evidence-based care using personal monitoring devices, prevention of chronic diseases, and keeping people healthy through wellness programs and incentives. Growth areas include online tools for patients, mobile health apps, chronic disease management, and social media for various healthcare uses. However, barriers include limited adoption by providers, data governance issues, lack of awareness, and the need for sustainable business models. Trust, financial alignment between stakeholders, and government support will also be important to address.
Biocon India Group should expand its operations through Clinigene, its clinical research subsidiary, to capture opportunities in the growing clinical trials market in India. The summary is:
1) Clinigene should expand from bioequivalence and bioavailability studies into clinical trials over 2 years by developing expertise, recruiting qualified staff, and securing clinical trial projects.
2) Factors to consider include maintaining Biocon's public image on ethical issues, protecting its organizational culture, and avoiding expertise divergence from other Biocon operations.
3) A phased expansion over 2 years allows Clinigene to establish itself while Biocon drafts an expansion plan and scouts required resources, minimizing risks to its reputation and operations.
This document summarizes findings from a field trip to Silicon Valley regarding options for Finnish healthtech startups to enter the US market. It outlines trends in health technology, interesting new startups, and the innovation ecosystem in Silicon Valley. It then discusses US gateway options such as accelerators, partners, and venture capital firms investing in health. Finally, it provides recommendations on understanding the market stage and category to determine the best entry approach.
El 12 de mayo de 2017 celebramos en la Fundación Ramó Areces una jornada con IS Global y Unitaid sobre enfermedades transmitidas por vectores, como la malaria, entre otras.
This document describes the Medical Device Gateway (MDG) program, a Chinese-Finnish network aimed at commercializing medical device technologies. The program seeks to bring Chinese medical device innovations to European markets through Finnish companies, and to open Chinese markets to Finnish medical ventures. It identifies opportunities in the large and growing Chinese IVD market and regulatory changes making it more accessible. The document outlines the program's operations of establishing strategic partnerships between Finnish and Chinese organizations to more quickly develop and place new products on global markets.
The post-COVID Value Shift & How MedTech Companies can CapitalizeGreenlight Guru
The ongoing COVID-19 pandemic has fundamentally shifted the perception of value globally. The healthcare industry, and MedTech (Devices, Diagnostics and Digital Health) stand to benefit enormously. While the world waits for a vaccine, it has been MedTech companies and their solutions that have protected healthcare workers, kept patients alive, and been the focus of government policy and investment. The policy and funding shifts have been aligned to value-based healthcare principals, of which MedTech was already a leader. Discover how you can align your organization, and engage with key stakeholders to capitalize on this massive shift in value perception.
Takeaways:
- How the fundamental structure of healthcare is set to change
-How this fundamental change will benefit MedTech companies
-What you need to do in order to make this change sustainable within your organization
This session took place live at the Greenlight Guru True Quality Virtual Summit, a three-day event for medical device professionals to learn to get their devices to market faster, stay ahead of regulatory changes, and use quality as their multiplier to grow their device business.
The document discusses strategies for collecting and analyzing COVID-19 related data to help pharmaceutical executives make decisions. It instructs the reader to prepare a 4-5 slide presentation comparing new COVID case rates before and after vaccination in their home country. Suggestions for the presentation include collecting data on vaccine hesitancy, infections without medical attention, and vaccine complications. References are provided on crude oil prices and Nigeria's COVID vaccination dashboard.
EMERGENCE OF NEW DIGITALIZATION TECHNIQUES IN ORGANISATIONS IN.pptxArunimaHazra2
The document discusses the emergence of new digitalization techniques adopted by organizations during the COVID-19 pandemic. It describes how the pandemic disrupted organizations, issues they faced, and the three-step response pattern of emergency response, crisis management, and focusing on the future. It also discusses digital trends that are likely to remain, including increased telework and adoption of digital solutions. The pandemic accelerated digital transformation, changing mindsets from "good-to-have" to "must-have." While some organizations adapted smoothly, the economic situation forced others to change. Overall, the pandemic highlighted the benefits of digital transformation.
1. Product development partnerships (PDPs) bridge the gap between industry and patients to develop diagnostic solutions for diseases that lack profitable treatments by collaborating with public and private partners.
2. 21 of the 28 diseases that primarily impact developing countries lack essential diagnostic tools, and companies have little incentive to invest in research and development without potential for profits.
3. PDPs can accelerate the development and access to diagnostics more quickly and cost-effectively than either the public or private sector alone by leveraging contributions from various partners.
The document summarizes a webinar on COVID-19 therapies and vaccines. It discusses the state of development for different therapeutic modalities, including antivirals, antibodies, and immunomodulators. It also discusses vaccine platforms under investigation, including nucleic acid, protein subunit, virus, and viral vector vaccines. Timelines for clinical trials and availability of leading candidates are provided. The need to prepare for large-scale production and delivery to meet target population goals is discussed. Partnerships across different organizations are highlighted as critical for success.
Through practical case studies and industry specific analysis sessions, Medical Device UDIs & Traceability Forum Europe 2015 is geared around strengthening your regulatory infrastructure, maintaining productivity and ensuring ROI from your UDI projects.
View the full agenda here: bit.ly/MedicalDeviceUDI2015Agenda
Alternatively, email enquire@iqpc.co.uk or call +44 (0)207 036 1300 for a copy.
DIGITAL TRANSFORMATION IN THE NEXT NORMAL: How consumerism, technology and th...Damo Consulting Inc.
What was assumed to be a transformation journey stretching over several years has now shrunk to a matter of months, and the pace of change is accelerating. Paddy Padmanabhan and Ed Marx, the authors of the first book published on healthcare digital transformation since the pandemic hit us, discuss 5 major themes in healthcare’s digital transformation, and what the next normal looks like.
They will present findings from recent research on how mid-tier systems must approach transformation.
1. How COVID-19 accelerated the timelines for transformation
2. Why health systems must go beyond just telehealth
3. Why digital leaders must develop enterprise roadmaps
4. How CIO’s can transform IT to support digital health
5. How technology decisions must deliver enterprise-level impact
The healthcare industry is being disrupted by technology and a shift to greater patient / individual empowerment. This represents a formidable opportunity for healthcare in Asia. What catalyst role could / should strategics play in Asia healthcare innovation and how?
The impact on covid 19 on business and how to reposition for success - intens...Intense
The spread of the COVID-19 virus has caused governments around the world including Nigeria to impose lockdowns on movement and this has affected most businesses adversely. We did some research to find out the challenges businesses are experiencing at this time and what areas they need help in to adapt to these drastic changes.
This presentation contains insights on what businesses can expect to happen in the short, medium and long term while also providing solutions to thrive in the new economy which will be largely digital.
Suddenly the risk-reward balance has shifted dramatically. Anyone with basic cold symptoms is being advised to stay home. And many people can no longer travel with COVID-19 in their community.
What if you can no longer visit your sites? Are you ready to use the tools at your disposal as contingency or risk-mitigation strategies to keep your studies going and ensure your patients can access their study medication and remain safely monitored?
During this virtual discussion forum were putting our minds together to combat the impact of the Coronavirus outbreak on clinical trials, and be better prepared in the future.
Baptist Health- Engineering the Future of HealthcareLevi Shapiro
Presentation by Mark Coticchia, Chief Innovation Officer, Baptist Health, for mHealth Israel community, September, 2023. Baptist Health has internationally renowned centers of excellence in cancer, cardiovascular care, orthopedics and sports medicine, and neurosciences.
A not-for-profit organization supported by philanthropy and committed to its faith-based charitable mission of medical excellence, Recognized by Fortune as one of the 100 Best Companies to Work For in America and by Ethisphere as one of the World’s Most Ethical Companies.Innovation is paramount to health system’s performance and reputation.
Becker’s 2019 Advisory Board survey revealed innovation and technology ranked as the top priority among healthcare finance professionals - up from eighth in 2018. 90% healthcare/life science leaders agree that the pandemic will fundamentally change the way they do business, requiring new products, services, processes, and business models (McKinsey: Innovation Through Crisis Survey). Innovation has been proven to help health systems in many ways. A capability and culture of innovation accomplish numerous goals:
Innovation capability and culture improve the care and work environment. They enhance the reputation through recognition for discoveries made at and through Baptist Health. They aid in the recruitment and retention of top talent. And they help systems harness money that otherwise would be leaving the system – licensing revenues and investment returns and corporate research support and donor revenues. Successful Programs - Common Underpinnings. Innovation as a strategic, institutional priority
Program built on institutional assets and centers of excellence
Experienced, professional team
Technology development and sourcing, Dedicated, long term support. Doing healthcare innovation well at a large enterprise takes a highly specialized team and skill set. Collectively, they need to have deep knowledge of healthcare regulation, medical procedures, patient safety, business development, transactions, business law, innovation markets, entrepreneurship, venture capital, commercialization, tech transfer, organizational change management, and much more. Programs- services, technology management, corporate co-creation, global medical service lines and facilities; Focus on market opportunity vs. technology; Select & concentrate on winners; Operate as a business; Proactive in new company formation; Progress, milestones, preliminary results; Building New Innovation Pathways; Improving Treatment for Cancer Patients; Predicting & Preventing Heart Attacks; Improving Outcomes in Cardiac Care; Enhancing a Culture of Innovation at Baptist Health & South Florida; Cleerly, TriVentures, COTA; Innovation is paramount to health system’s performance and reputation.
Baptist Health has established an innovation function predicated on best practices and tailored to its assets and the opportunities extending from Miami’s economic growth
The document discusses PositiveID's portfolio of products for biological detection and diagnostics. It summarizes key products like Firefly Dx, a handheld molecular diagnostic device, and M-BAND, an automated bio-threat detection system. It also discusses recent acquisitions of E-N-G, a provider of mobile labs, and Caregiver, a non-contact thermometer. PositiveID aims to commercialize Firefly Dx in 2018 after field testing in 2017. The company has experienced growing revenue, reaching $2.9 million in 2015 and projecting $5-6 million for 2016 through its expanding product lines and recent acquisitions.
Innovating for health mObile Health perspectiveRuchi Dass
In the face of the enormous challenges of managing chronic diseases, delivery innovations appear to have the most impact when multiple parties (e.g., physicians, nurses, payors) interact seamlessly to provide the best possible patient care over an extended period of time. Such integrated models have the potential to reduce costs dramatically, while increasing patient satisfaction and clinical quality
THE SPECIAL SENCES- Unlocking the Wonders of the Special Senses: Sight, Sound...Nursing Mastery
Title: Unlocking the Wonders of the Special Senses: Sight, Sound, Smell, Taste, and Balance
Introduction:
Welcome to our captivating SlideShare presentation on the Special Senses, where we delve into the extraordinary capabilities that allow us to perceive and interact with the world around us. Join us on a sensory journey as we explore the intricate structures and functions of sight, sound, smell, taste, and balance.
The special senses are our primary means of experiencing and interpreting the environment, each sense providing unique and vital information that shapes our perceptions and responses. These senses are facilitated by highly specialized organs and complex neural pathways, enabling us to see a vibrant sunset, hear a symphony, savor a delicious meal, detect a fragrant flower, and maintain our equilibrium.
In this presentation, we will:
Visual System (Sight): Dive into the anatomy and physiology of the eye, exploring how light is converted into electrical signals and processed by the brain to create the images we see. Understand common vision disorders and the mechanisms behind corrective measures like glasses and contact lenses.
Auditory System (Hearing): Examine the structures of the ear and the process of sound wave transduction, from the outer ear to the cochlea and auditory nerve. Learn about hearing loss, auditory processing, and the advances in hearing aid technology.
Olfactory System (Smell): Discover the olfactory receptors and pathways that enable the detection of thousands of different odors. Explore the connection between smell and memory and the impact of olfactory disorders on quality of life.
Gustatory System (Taste): Uncover the taste buds and the five basic tastes – sweet, salty, sour, bitter, and umami. Delve into the interplay between taste and smell and the factors influencing our food preferences and eating habits.
Vestibular System (Balance): Investigate the inner ear structures responsible for balance and spatial orientation. Understand how the vestibular system helps maintain posture and coordination, and explore common vestibular disorders and their effects.
Through engaging visuals, interactive diagrams, and insightful explanations, we aim to illuminate the complexities of the special senses and their profound impact on our daily lives. Whether you're a student, educator, or simply curious about how we perceive the world, this presentation will provide valuable insights into the remarkable capabilities of the human sensory system.
Join us as we unlock the wonders of the special senses and gain a deeper appreciation for the intricate mechanisms that allow us to experience the richness of our environment.
Cyclothymia Test: Diagnosing, Symptoms, Treatment, and Impact | The Lifescien...The Lifesciences Magazine
The cyclothymia test is a pivotal tool in the diagnostic process. It helps clinicians assess the presence and severity of symptoms associated with cyclothymia.
The Ultimate Guide in Setting Up Market Research System in Health-TechGokul Rangarajan
How to effectively start market research in the health tech industry by defining objectives, crafting problem statements, selecting methods, identifying data collection sources, and setting clear timelines. This guide covers all the preliminary steps needed to lay a strong foundation for your research.
"Market Research it too text-booky, I am in the market for a decade, I am living research book" this is what the founder I met on the event claimed, few of my colleagues rolled their eyes. Its true that one cannot over look the real life experience, but one cannot out beat structured gold mine of market research.
Many 0 to 1 startup founders often overlook market research, but this critical step can make or break a venture, especially in health tech.
But Why do they skip it?
Limited resources—time, money, and manpower—are common culprits.
"In fact, a survey by CB Insights found that 42% of startups fail due to no market need, which is like building a spaceship to Mars only to realise you forgot the fuel."
Sudharsan Srinivasan
Operational Partner Pitchworks VC Studio
Overconfidence in their product’s success leads founders to assume it will naturally find its market, especially in health tech where patient needs, entire system issues and regulatory requirements are as complex as trying to perform brain surgery with a butter knife. Additionally, the pressure to launch quickly and the belief in their own intuition further contribute to this oversight. Yet, thorough market research in health tech could be the key to transforming a startup's vision into a life-saving reality, instead of a medical mishap waiting to happen.
Example of Market Research working
Innovaccer, founded by Abhinav Shashank in 2014, focuses on improving healthcare delivery through data-driven insights and interoperability solutions. Before launching their platform, Innovaccer conducted extensive market research to understand the challenges faced by healthcare organizations and the potential for innovation in healthcare IT.
Identifying Pain Points: Innovaccer surveyed healthcare providers to understand their difficulties with data integration, care coordination, and patient engagement. They found widespread frustration with siloed systems and inefficient workflows.
Competitive Analysis: Analyzed competitors offering similar solutions in healthcare analytics and interoperability. Identified gaps in comprehensive data aggregation, real-time analytics, and actionable insights.
Regulatory Compliance: Ensured their platform complied with HIPAA and other healthcare data privacy regulations. This compliance was crucial to gaining trust from healthcare providers wary of data security issues.
Customer Validation: Conducted pilot programs with several healthcare organizations to validate the platform's effectiveness in improving care outcomes and operational efficiency. Gathered feedback to refine features and user interface.
Satisfying Spa Massage Experience at Just 99 AED - Malayali Kerala Spa AjmanMalayali Kerala Spa Ajman
Our Spa Massage Center Ajman prioritizes efficiency to ensure a satisfying massage experience for our clients at Malayali Kerala Spa Ajman. We offer a hassle-free appointment system, effective health issue identification, and precise massage techniques.
Our Spa in Ajman stands out for its effectiveness in enhancing wellness. Our therapists focus on treating the root cause of issues, providing tailored treatments for each client. We take pride in offering the most satisfying Pakistani Spa service, adjusting treatment plans based on client feedback.
For the most result-oriented Russian Spa treatment in Ajman, visit our Massage Center. Our Russian therapists are skilled in various techniques to address health concerns. Our body-to-body massage is efficient due to individualized care and high-grade massage oils.
VEDANTA AIR AMBULANCE SERVICES IN REWA AT A COST-EFFECTIVE PRICE.pdfVedanta A
Air Ambulance Services In Rewa works in close coordination with ground-based emergency services, including local Emergency Medical Services, fire departments, and law enforcement agencies.
More@: https://tinyurl.com/2shrryhx
More@: https://tinyurl.com/5n8h3wp8
English Drug and Alcohol Commissioners June 2024.pptxMatSouthwell1
Presentation made by Mat Southwell to the Harm Reduction Working Group of the English Drug and Alcohol Commissioners. Discuss stimulants, OAMT, NSP coverage and community-led approach to DCRs. Focussing on active drug user perspectives and interests
At Malayali Kerala Spa Ajman we providing the top quality massage services for our customers.
Our massage center prioritizes efficiency to ensure a quality massage experience for our clients at Malayali Kerala Spa Ajman. We offer a convenient appointment system and precise massage services.
Reach us at Villa No 7, Near Ammar Bin Yasir Street Al Rashidiya 2 - Ajman - United Arab Emirates.
Phone : +971 529818279
About CentiUP - Introduction and Products.pdfCentiUP
A heightened child formula, with the trio of Nano Calcium, HMO, and DHA mixed in the golden ratio, combined with NANO technology to help nourish the body deeply and comprehensively, helps children increase height, boost brain power, and improve the immune system and overall well-being.
Exploring Stem Cell Solutions for Parkinson's Disease with Dr. David Greene A...Dr. David Greene Arizona
Dr. David Greene of Arizona is at the forefront of stem cell therapy for Parkinson's Disease, focusing on innovative treatments to restore dopamine-producing neurons. His research explores the use of embryonic stem cells, induced pluripotent stem cells, and adult stem cells to replace lost neurons and potentially reverse disease progression. By transplanting differentiated cells into affected brain areas, Dr. Greene aims to address the root cause of Parkinson's. His work also investigates the neuroprotective benefits of stem cells, offering hope for effective, long-term treatments. Discover how Dr. Greene's pioneering efforts could transform Parkinson's Disease therapy.
2. Agenda
▪ Part 1: HealthcareLandscape
▪ 4 D’s of Core Healthcare Innovation and OtherAreas
▪ Key Paths for success of Healthcare companies
▪ Part 2: Opportunities with Covid-19
▪ Telemedicine and PPE
▪ Testing and Curing
▪ Software and Devices
▪ Programs where you can find funding
4. 4 D’s of Core Healthcare Innovation
▪ Drug: Extremely risky, expensive and long. India has practically not made a mark here.
▪ Biosimilars have seen some success, Immunologics seem like the next step
▪ Some early discoveries by Biotech in India got licensed out to Big Pharma
▪ Diagnostics: Indian Biotech is good at creating novel methods
▪ Several biomarker-based discoveries have happened over last 10 years
▪ Ability in making novel biomedical instrumentationhas helped our case
▪ Devices: Alot of novel innovations have taken place, thanks to BIRAC, but not a lot of
commercialization since it is time consuming and also relatively risky
▪ Data: This is where India shines. Companies like Tricog are making world-beating algorithms
5. Other Healthcare Opportunity Areas
▪ Marketplaces: Medicine, Consultation, Diagnostics, Surgery and Gyms are available on a click!
▪ Companies like 1mg, Practo, Healhians, Prystyn Care, Fitpass operate on this model
▪ Network / Tools: DailyRounds, Curofy, DocsApp help doctors perform better
▪ Services: Mental Health, Chronic disease management, Weight loss offerings
▪ Wysa, BeatO, HealthifyMe are examples of this set
6. How to Build a Successful Healthcare Startup
▪ Assuming Basics like having a qualified team, novel idea, strong will to succeed, some other
things that matter are:
▪ Strong Medical Team:
▪ Doctors love to speak to a doctor, much more than MBA-types
▪ Having an insider helps you build better products – brutal feedback is necessary
▪ Understanding of Regulation and Clinical Rigor:
▪ Shortens the path to market if you have already figured this out
▪ The way you prepare the documentation and trials determines your way to succeed
▪ Empathy for the Practitioner:
▪ Assuming you know what to make is often faulty thought in Healthcare
8. Opportunities with Covid-19 – Telemedicine and PPEs
▪ Need for Telemedicine:
▪ Given Covid-19 situations, there’s a global surge in demand for Healthcare while the supply
is limited. A physician’s time can be leveraged with technology if remote patients can avail
consultation from their homes.
▪ Specialists can help GPs expand their ability by consulting them on complicated matters
and avoid patients reaching out to bigger cities/hospitals and loading them.
▪ Need for PPEs:
▪ India does not produce enough N95 masks. In the sudden surge in demand (peak being in
millions per day) we are expecting, this has become a critical challenge.
▪ Other challenges are related to lockdown – raw material and labor being unavailable – and
working capital – manufacturers not having enough.
9. Opportunities with Covid-19 – Testing and Curing
▪ Need for Testing:
▪ Imported test kits are both expensive and fewer in quantity. Already 5-6 such
kits are approved and more would hit the market soon.
▪ There’s need to develop other novel methods to test Covid-19.
▪ Further, administering these tests without touching the patient is a need.
▪ A cure is elusive:
▪ Several efforts are on to produce a vaccine, others for repurposing a drug
for this indication.
▪ There will also be programs given to masses to prevent outbreaks in future.
10. Opportunities with Covid-19 – Software and Devices
▪ Need for Software:
▪ Contact tracing is already a big hit in China and Korea. India has launched its own Aarogya
Setu. Alternate methods to track patients and hotspots is critical.
▪ Multiple different platforms are needed:
▪ Helping donations reach various NGOs helping migrant labor and others
▪ Helping essential SMEs access working capital
▪ State/District/Taluka level dashboard for tracking and dealing with Covid-19
▪ Need for novel Devices:
▪ Developing new ventilators that are cheap and quick to produce is the #1 need right now.
▪ Can you track and monitor patients in quarantine outside hospital?
▪ Creating mini-ICUs that can function with limited skill and hardware
▪ Can you create a device than can reduce Hospital-Induced Infections?
11. Opportunities with Covid-19 – Funding Opportunities
▪ Government Funding:
▪ SIDBI has created a scheme for startups to access working capital at preferential terms.
▪ DST has launched a program CAWACH under SINE, IIT Bombay
▪ DBT has launched a similar program with C-CAMP, Bengaluru
▪ BIRAC is talking about bulk procurement of devices and testing and PPEs
▪ Private Sector:
▪ ACT Grants – a group of VCs and startups in India. Arpit and I are volunteering.
▪ Marico Foundation – Grant proposals of various kinds
▪ Premji Foundation, Tata Trusts, Infosys Foundation, Reliance Foundation all have programs